BibTex RIS Cite

Akılcı İlaç Kullanımı

Year 2014, Volume: 3 Issue: 2, 32 - 35, 01.10.2014

Mustafa Sağır Hakan Parlakpınar

Abstract

Dünya Sağlık Örgütü tahminlerine göre tüm ilaçların yarısından fazlası uygunsuz şekilde reçete edilmektedir. Akılcı İlaç Kullanımı AİK , “hastaların klinik ihtiyaçlarına uygun ilaçları, kişisel gereksinimlerini karşılayan dozlarda, yeterli bir süre boyunca, kendilerine ve topluma en az maliyet ile kullanmaları” olarak tanımlanmıştır. AİK basamakları; doğru tanının konulması, prognozun izlenmesi, tedavi amaçlarının saptanması, tedavi seçeneklerinin gözden geçirilmesi, gerekli ise reçetenin doğru biçimde yazımı ve takiptir. Tüm bu süreçte ilaç dışı tedavi yaklaşımlarının dikkate alınması, ilaçlar için etkinlik, uygunluk, güvenlilik ve maliyet analizinin yapılması, doğru bilgilendirme ve hasta katılımının sağlanması esastır.

Keywords

Akılcı İlaç Kullanımı Tıp Eğitimi Klinik Farmakoloji

References

  • 1. De Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guide to Good Prescribing. WHO/Action programme on essential drugs, Geneva, 1994.
  • 2. Promoting rational drug use. Trainer’s guide. Accra, Ghana; 15-27 Kasım 1998.
  • 3. WHO/DAP. How to investigate drug use in health facilities: selected drug use indicators. Geneva. World Health Organization. 1993. WHO / DAP / 93.1.
  • 4. WHO/EDM/PAR. Teacher’s guide to good prescribing. World Health Organization Essential Drugs and Medicines Policy Geneva. 2001 WHO/EDM/PAR/2001.2
  • 5. Walley T, Bligh J. The educational challenge of improving prescribing. Postgrad Edu Gen Prac 1993; 4: 50-4.
  • 6. Cottingham J. (2003) Akılcılık (Çev. Gozkan B), Doruk Yayıncılık, İstanbul.
  • 7. Marshall G. (2003) Sosyoloji Sözlüğü (Çev. Akınhay O, Kömürcü D) Bilim ve Sanat Yayınları, Ankara.
  • 8. Aydın B, Gelal A. Akılcı ilaç kullanımı: Yaygınlaştırılması ve tıp eğitiminin rolü. DEU Tıp Fakültesi Dergisi 2012, 26: (1) 57-63.
  • 9. Lu Y, Hernandez P, Abegunde D, Edejer T. The world medicines situation 2011. Medicine expenditures. Third edition. World Health Organization, Geneva 2011.
  • 10. Maxwell S. Rational prescribing: the principles of drug selection. Clin Med 2009; 9: 481-5.
  • 11. World Health Organization. WHO Policy perspectives on medicines. Promoting rational use of medicines: core components. Geneva, Sep 2002.
  • 12. Le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM. Intervention research in rational use of drugs: a review. Health Policy and Plan 1999; 14: 89-102.
  • 13. Akici A, Kalaca S, Goren MZ, Akkan AG, Karaalp A, Demir D, Ugurlu U, Oktay S. Comparison rational pharmacotherapy decision making competence of general practitioners with intern doctors. Eur J Clin Pharmacol 2004; 60: 75-82.
  • 14. Akici A, Goren MZ, Aypak C, Terzioglu B, Oktay S. Prescription audit adjunct to rational pharmacotherapy education improves prescribing skills of medical students. Eur J Clin Pharmacol 2005; 61(9): 643-50.
  • 15. Hassan NAGM, Abdulla AA, Bakathir HA, Al-Amoodi AA, Aklan AM, TPGM de Vries. The impact of problembased pharmacotherapy training on the competence of rational prescribing of Yemen undergraduate students. Eur J Clin Pharmacol 2000; 55: 873-6.
  • 16. De Vries TPGM, Henning RH, Hogerzeil HV, et al. Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomized controlled study. Lancet 1995; 346: 1454-7.
  • 17. Veninga CCM, Lundborg CS, Lagerlov P, HummersPradier E, Denig P, Haaijer Ruskamp FM. Treatment of uncomplicated urinary tract infections: exploring differences in adherence to guidelines between three European countries. Ann Pharmacother 2000a; 34: 19- 26.
  • 18. Veninga CCM, Denig P, Zwaagstra R, HaaijerRuskamp FM. Improving drug treatment in general practice. J Clin Epidemiol 2000b; 53: 762-72.
  • 19. Tomson Y, Hasselstrom J, Tomson G, Aberg H. Asthma education for Swedish primary care physiciansa study on the effects of “academic detailing” on practice and patient knowledge. Eur J Clin Pharmacol 1997; 53: 191-6.
  • 20. Melli M. Akılcı İlaç Kullanımı. Anestezi Dergisi 2010; 18 (3): 131-4.
  • 21. Ro Laing, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 2001; 16(1): 13-20.
  • 22. Akıcı A, Gelal A, Erenmemişoglu A, Melli M, Babaoğlu M, Oktay S. Akılcı İlaç Kullanımı Eğitimi Uygulama Sürecinde Türkiye’deki Tıp Fakültelerinde Farmakoloji Anabilim Dallarının Durumunun İncelenmesi. Tıp Eğitimi Dünyası 2011; 29: 11-20.
  • 23. Ross S, Loke YK. Do educational interventions improve prescribing by medical students and junior doctors. A systematic review. Br J Clin Pharmacol 2009; 67: 662-70
  • 24. Maxwell SR, Cascorbi I, Orme M, Webb DJ; Joint BPS/EACPT Working Group on Safe Prescribing. Educating European (junior) doctors for safe prescribing. Basic Clin Pharmacol & Toxicol 2007; 101: 395-400.
  • 25. Hocaoğlu N, Güven H, Gidener S ve ark. Dokuz Eylül Üniversitesi Tıp Fakültesi dördüncü sınıf öğrencilerinin akılcı ilaç kullanım becerileri üzerine akılcı ilaç kullanım kursunun kısa dönem etkileri. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi 2011; 25: 15-24.
  • 26. Guney Z, Uluoglu C, Yucel B, Coskun O. The impact of rational pharmacotherapy training reinforced via prescription audit on the prescribing skills of fifth-year medical students. Int J Clin Pharmacol Ther 2009; 47: 671-78.
  • 27. Sılan C. Donem IV ve V öğrencilerine uygulanan akılcı ilaç seçimi ve kullanımı eğitimine ilişkin 6 yıllık sonuçlar. 21. Ulusal Farmakoloji Kongresi. Kongre Kitabı 2011: 378.
  • 28. Akici A, Kalaca S, Ugurlu MU et al. Impact of a short postgraduate course in rational pharmacotherapy for general practitioners. Br J Clin Pharmacol 2003; 57: 310–21.
  • 29. Ocek Z, Sahin H, Baksi G et al. Development of a rational antibiotic usage course for dentists. Eur J Dent Educ 2008; 12: 41–7.

Rational Use of Medicaments

Year 2014, Volume: 3 Issue: 2, 32 - 35, 01.10.2014

Mustafa Sağır Hakan Parlakpınar

Abstract

World Health Organization estimates that more than half of all drugs are inappropriately prescribed. Rational drug use is desribed as "patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period, and at the lowest cost to them and their community" Steps for rational drug use are diagnosing correctly, screening prognosis, defining treatment targets, considering treatment options, prescribing correctly if necessary, and following up the patient. During this process, considering non-pharmacological approachs other than drugs; analyzing drugs for efficacy, suitability, safety, and cost, correct informing, and ensuring patient involvement are essential.

Keywords

Rational Drug Use Medical Education Clinical Pharmacology.

References

  • 1. De Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guide to Good Prescribing. WHO/Action programme on essential drugs, Geneva, 1994.
  • 2. Promoting rational drug use. Trainer’s guide. Accra, Ghana; 15-27 Kasım 1998.
  • 3. WHO/DAP. How to investigate drug use in health facilities: selected drug use indicators. Geneva. World Health Organization. 1993. WHO / DAP / 93.1.
  • 4. WHO/EDM/PAR. Teacher’s guide to good prescribing. World Health Organization Essential Drugs and Medicines Policy Geneva. 2001 WHO/EDM/PAR/2001.2
  • 5. Walley T, Bligh J. The educational challenge of improving prescribing. Postgrad Edu Gen Prac 1993; 4: 50-4.
  • 6. Cottingham J. (2003) Akılcılık (Çev. Gozkan B), Doruk Yayıncılık, İstanbul.
  • 7. Marshall G. (2003) Sosyoloji Sözlüğü (Çev. Akınhay O, Kömürcü D) Bilim ve Sanat Yayınları, Ankara.
  • 8. Aydın B, Gelal A. Akılcı ilaç kullanımı: Yaygınlaştırılması ve tıp eğitiminin rolü. DEU Tıp Fakültesi Dergisi 2012, 26: (1) 57-63.
  • 9. Lu Y, Hernandez P, Abegunde D, Edejer T. The world medicines situation 2011. Medicine expenditures. Third edition. World Health Organization, Geneva 2011.
  • 10. Maxwell S. Rational prescribing: the principles of drug selection. Clin Med 2009; 9: 481-5.
  • 11. World Health Organization. WHO Policy perspectives on medicines. Promoting rational use of medicines: core components. Geneva, Sep 2002.
  • 12. Le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM. Intervention research in rational use of drugs: a review. Health Policy and Plan 1999; 14: 89-102.
  • 13. Akici A, Kalaca S, Goren MZ, Akkan AG, Karaalp A, Demir D, Ugurlu U, Oktay S. Comparison rational pharmacotherapy decision making competence of general practitioners with intern doctors. Eur J Clin Pharmacol 2004; 60: 75-82.
  • 14. Akici A, Goren MZ, Aypak C, Terzioglu B, Oktay S. Prescription audit adjunct to rational pharmacotherapy education improves prescribing skills of medical students. Eur J Clin Pharmacol 2005; 61(9): 643-50.
  • 15. Hassan NAGM, Abdulla AA, Bakathir HA, Al-Amoodi AA, Aklan AM, TPGM de Vries. The impact of problembased pharmacotherapy training on the competence of rational prescribing of Yemen undergraduate students. Eur J Clin Pharmacol 2000; 55: 873-6.
  • 16. De Vries TPGM, Henning RH, Hogerzeil HV, et al. Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomized controlled study. Lancet 1995; 346: 1454-7.
  • 17. Veninga CCM, Lundborg CS, Lagerlov P, HummersPradier E, Denig P, Haaijer Ruskamp FM. Treatment of uncomplicated urinary tract infections: exploring differences in adherence to guidelines between three European countries. Ann Pharmacother 2000a; 34: 19- 26.
  • 18. Veninga CCM, Denig P, Zwaagstra R, HaaijerRuskamp FM. Improving drug treatment in general practice. J Clin Epidemiol 2000b; 53: 762-72.
  • 19. Tomson Y, Hasselstrom J, Tomson G, Aberg H. Asthma education for Swedish primary care physiciansa study on the effects of “academic detailing” on practice and patient knowledge. Eur J Clin Pharmacol 1997; 53: 191-6.
  • 20. Melli M. Akılcı İlaç Kullanımı. Anestezi Dergisi 2010; 18 (3): 131-4.
  • 21. Ro Laing, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 2001; 16(1): 13-20.
  • 22. Akıcı A, Gelal A, Erenmemişoglu A, Melli M, Babaoğlu M, Oktay S. Akılcı İlaç Kullanımı Eğitimi Uygulama Sürecinde Türkiye’deki Tıp Fakültelerinde Farmakoloji Anabilim Dallarının Durumunun İncelenmesi. Tıp Eğitimi Dünyası 2011; 29: 11-20.
  • 23. Ross S, Loke YK. Do educational interventions improve prescribing by medical students and junior doctors. A systematic review. Br J Clin Pharmacol 2009; 67: 662-70
  • 24. Maxwell SR, Cascorbi I, Orme M, Webb DJ; Joint BPS/EACPT Working Group on Safe Prescribing. Educating European (junior) doctors for safe prescribing. Basic Clin Pharmacol & Toxicol 2007; 101: 395-400.
  • 25. Hocaoğlu N, Güven H, Gidener S ve ark. Dokuz Eylül Üniversitesi Tıp Fakültesi dördüncü sınıf öğrencilerinin akılcı ilaç kullanım becerileri üzerine akılcı ilaç kullanım kursunun kısa dönem etkileri. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi 2011; 25: 15-24.
  • 26. Guney Z, Uluoglu C, Yucel B, Coskun O. The impact of rational pharmacotherapy training reinforced via prescription audit on the prescribing skills of fifth-year medical students. Int J Clin Pharmacol Ther 2009; 47: 671-78.
  • 27. Sılan C. Donem IV ve V öğrencilerine uygulanan akılcı ilaç seçimi ve kullanımı eğitimine ilişkin 6 yıllık sonuçlar. 21. Ulusal Farmakoloji Kongresi. Kongre Kitabı 2011: 378.
  • 28. Akici A, Kalaca S, Ugurlu MU et al. Impact of a short postgraduate course in rational pharmacotherapy for general practitioners. Br J Clin Pharmacol 2003; 57: 310–21.
  • 29. Ocek Z, Sahin H, Baksi G et al. Development of a rational antibiotic usage course for dentists. Eur J Dent Educ 2008; 12: 41–7.
There are 29 citations in total.

Details

Primary Language Turkish
Journal Section Research Article
Authors

Mustafa Sağır This is me

Hakan Parlakpınar This is me

Publication Date October 1, 2014
Published in Issue Year 2014 Volume: 3 Issue: 2

Cite

APA Sağır, M., & Parlakpınar, H. (2014). Akılcı İlaç Kullanımı. Annals of Health Sciences Research, 3(2), 32-35.
AMA Sağır M, Parlakpınar H. Akılcı İlaç Kullanımı. Ann Health Sci Res. October 2014;3(2):32-35.
Chicago Sağır, Mustafa, and Hakan Parlakpınar. “Akılcı İlaç Kullanımı”. Annals of Health Sciences Research 3, no. 2 (October 2014): 32-35.
EndNote Sağır M, Parlakpınar H (October 1, 2014) Akılcı İlaç Kullanımı. Annals of Health Sciences Research 3 2 32–35.
IEEE M. Sağır and H. Parlakpınar, “Akılcı İlaç Kullanımı”, Ann Health Sci Res, vol. 3, no. 2, pp. 32–35, 2014.
ISNAD Sağır, Mustafa - Parlakpınar, Hakan. “Akılcı İlaç Kullanımı”. Annals of Health Sciences Research 3/2 (October 2014), 32-35.
JAMA Sağır M, Parlakpınar H. Akılcı İlaç Kullanımı. Ann Health Sci Res. 2014;3:32–35.
MLA Sağır, Mustafa and Hakan Parlakpınar. “Akılcı İlaç Kullanımı”. Annals of Health Sciences Research, vol. 3, no. 2, 2014, pp. 32-35.
Vancouver Sağır M, Parlakpınar H. Akılcı İlaç Kullanımı. Ann Health Sci Res. 2014;3(2):32-5.